RBx 5736
Latest Information Update: 20 Nov 2006
At a glance
- Originator Ranbaxy Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 09 Dec 2003 No development reported - Preclinical for Benign prostatic hyperplasia in India (PO)
- 30 Oct 2000 Preclinical development for Benign prostatic hyperplasia in India (PO)
- 15 Jun 2000 New profile